Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Guatteria gaumeri 30C: Guatteria gaumeri 30C, each dose consisting of 6 medicated globules (globule no.- 20). Dose and repetition will be decided as per requirement of the case on the b
Sponsors
Dr. Tanya Wadhwa National Institute of Homoeopathy, Kolkata
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patents with low (10%) and intermediate (10-19%) risk in Framingham score (estimation of 10 years CVD risk) will be included in the study. 2. Patients of all genders, different religions and socio-economic groups. 3. Patients of age group 20-60 years. 4. Patients with serum LDL levels between 100-200 mg/dl. 5. Patients willing to give written consent for participating in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with high risk (= 20%) in Framingham Risk score. 2. Patients taking statin therapy. 3. Patients having systemic illness, malignancy, immuno-compromised state, psychiatric illness. 4. Patients who are pregnant, lactating, or taking oral contraceptive pills or hormonal therapy. 5. Patients taking anti-diabetic and/or anti-hypertensive medicines. 6. Patients unwilling to take part or give consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum LDL levelsTimepoint: At the baseline and after 3 months of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Naranjo Criteria for Homeopathy (MONARCH).Timepoint: After 3 months of treatment | — |
Countries
India
Contacts
Public ContactDr. Tanya Wadhwa
NATIONAL INSTITUTE OF HOMOEOPATHY
Outcome results
None listed